Association of the human bradykinin B2 receptor gene with chronic renal failure

Freedman BI, Bowden DW. The role of genetic factors in the development of end-stage renal disease. Curr Opin Nephrol Hypertens 1995 May; 4(3): 230–4

Freedman BI. Susceptibility genes for hypertension and renal failure. J Am Soc Nephrol 2003 Jul; 14 Suppl. 2: S192–4

Margolius HS. Kallikreins and kinins: some unanswered questions about system characteristics and roles in human disease. Hypertension 1998 Aug; 26(2): 221–9

Schölkens BA. Kinins in the cardiovascular system. Immunopharmacology 1996 Jun; 33(1-3): 209–16

Wang DZ, Chao L, Chao J. Hypotension in transgenic mice overexpressing human bradykinin B2 receptor. Hypertension 1997 Jan; 29 (1 Pt 2): 488–93

Madeddu P, Milia AF, Salis MB, et al. Renovascular hypertension in bradykinin B2 receptor knockout mouse. Hypertension 1998 Sep; 32(3): 503–9

Hutchison FN, Martin VI. Effects of modulation of renal kallikrein-kinin system in the nephritic syndrome. Am J Physiol 1990 May; 258 (5 Pt 2): F1237–44

Uehara Y, Hirawa N, Numabe A. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Am J Hypertens 1997 May; 10 (5 Pt 2): S83–8

Zychma MJ, Gumprecht J, Zukowska-Szczechowska E, et al. Polymorphisms in the genes encoding for human kinin receptors and the risk of end-stage renal failure: results of transmission/disequilibrium test. J Am Soc Nephrol 1999 Oct; 10(10): 2120–4

Prado GN, Taylor L, Zhou X, et al. Mechanisms regulating the expression, self maintenance and signaling-function of the bradykinin B2 and B1 receptors. J Cell Physiol 2002 Dec; 193(3): 275–86

Blaukat A. Structure and signaling pathways of kinin receptors. Andrologia 2003 Feb; 35(1): 17–23

Marceau F, Sabourin T, Houle S, et al. Kinin receptors: functional aspects. Int Immunopharmacol 2002 Dec; 2(13-14): 1729–39

Braun A, Kammerer S, Böhme E. Identification of polymorphic sites of the human bradykinin B2 receptor gene. Biochem Biophys Res Comm 1995 Jun; 211(1): 234–40

Braun A, Kammerer S, Maier E, et al. Polymorphisms in the gene for the human B2-bradykinin receptor: new tools in assessing a genetic risk for bradykinin-associated diseases. Immunopharmacology 1996 Jun; 33(1–3): 32–5

Mukae S, Aoki S, Itoh S, et al. Promoter polymorphism of the B2-bradykinin receptor gene is associated with essential hypertension. Jpn Circ J 1999 Oct; 63(10): 759–62

Gainer JV, Brown NJ, Bachvarova M, et al. Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans. Am J Hypertens 2000 Dec; 13(12): 1268–73

Wang B, Aiming D, Liu G. Genetic variation in the promoter region of the B2-bradykinin receptor gene is associated with essential hypertension in a Chinese Han population. Hypertens Res 2001 May; 24(3): 299–302

Mulatero P, Williams TA, Milan A, et al. Blood pressure in patients with primary aldosteronism is influenced by bradykinin B2 receptor and α-adducin gene polymorphisms. J Clin Endocrinol Metab 2002 Jul; 87(7): 3337–43

Erdmann J, Hegemann N, Weidemann A, et al. Screening the human bradykinin B2 receptor gene in patients with cardiovascular diseases: identification of a functional mutation in the promoter and a new coding variant (T21M). Am J Med Genet 1998 Dec; 80(5): 521–5

Dhamrait SS, Payne JR, Li P, et al. Variation in bradykinin receptor gene increases the cardiovascular risk associated with hypertension. Eur Heart J 2003 Sep; 24(18): 1672–80

Kusser B, Braun A, Praun M, et al. Polymorphisms in the bradykinin B2 receptor gene and childhood asthma. Biol Chem 2001 May; 382(5): 885–9

Bachvarov D, Landry M, Pelletier I, et al. Characterization of two polymorphic sites in the human kinin B1 receptor gene: altered frequency of an allele in patients with a history of end-stage renal failure. J Am Soc Nephrol 1998 Apr; 9(4): 598–604

Madisen L, Hoar LD, Holroyd CD, et al. DNA banking: the effects of storage of blood and isolated DNA on integrity of DNA. Am J Med Genet 1987 Jun; 27(2): 379–90

Abd Alla S, Quitterer U, Schroder C, et al. On the structure of the amino-terminal domain ED1 of the B2 receptor. Immunopharmacology 1996 Oct; 33(1): 42–5